Sign in
8-K/A

Current Report

Viridian Therapeutics, Inc.DE Filed Acc 0001193125-21-191326

Bylaws or fiscal year change · Shareholder vote results

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d192569d8ka.htm…